Skip to Main content Skip to Navigation
Journal articles

Human IgG1 antibodies suppress angiogenesis in a target-independent manner.

Abstract : Aberrant angiogenesis is implicated in diseases affecting nearly 10% of the world's population. The most widely used anti-angiogenic drug is bevacizumab, a humanized IgG1 monoclonal antibody that targets human VEGFA. Although bevacizumab does not recognize mouse Vegfa, it inhibits angiogenesis in mice. Here we show bevacizumab suppressed angiogenesis in three mouse models not via Vegfa blockade but rather Fc-mediated signaling through FcγRI (CD64) and c-Cbl, impairing macrophage migration. Other approved humanized or human IgG1 antibodies without mouse targets (adalimumab, alemtuzumab, ofatumumab, omalizumab, palivizumab and tocilizumab), mouse IgG2a, and overexpression of human IgG1-Fc or mouse IgG2a-Fc, also inhibited angiogenesis in wild-type and FcγR humanized mice. This anti-angiogenic effect was abolished by Fcgr1 ablation or knockdown, Fc cleavage, IgG-Fc inhibition, disruption of Fc-FcγR interaction, or elimination of FcRγ-initated signaling. Furthermore, bevacizumab's Fc region potentiated its anti-angiogenic activity in humanized VEGFA mice. Finally, mice deficient in FcγRI exhibited increased developmental and pathological angiogenesis. These findings reveal an unexpected anti-angiogenic function for FcγRI and a potentially concerning off-target effect of hIgG1 therapies.
Document type :
Journal articles
Complete list of metadatas

Cited literature [95 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-02511158
Contributor : Marie Martin <>
Submitted on : Wednesday, March 18, 2020 - 3:28:48 PM
Last modification on : Friday, October 23, 2020 - 4:34:49 PM

File

sigtrans20151.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Sasha Bogdanovich, Younghee Kim, Takeshi Mizutani, Reo Yasuma, Laura Tudisco, et al.. Human IgG1 antibodies suppress angiogenesis in a target-independent manner.. Signal Transduction and Targeted Therapy, Nature.com, 2016, 1, pp.15001. ⟨10.1038/sigtrans.2015.1⟩. ⟨pasteur-02511158⟩

Share

Metrics

Record views

123

Files downloads

271